Using continuous glucose monitors for diabetes management after hospital discharge
Official title: Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
Run by Vanderbilt University Medical Center · NCT06852950 · Data updated 2026-11-12
This study is testing if using continuous glucose monitors can help adults with diabetes manage their blood sugar better after leaving the hospital.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | March 9, 2025 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | March 5, 2026 |
| Trial ID | NCT06852950 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are non-pregnant adults aged 18 and older with hyperglycemia requiring insulin therapy during hospitalization.
✕Probably not a fit
Patients currently using continuous glucose monitoring systems or those with certain medical conditions, such as recent chemotherapy or planned major surgery, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on enhancing diabetes management for patients transitioning from hospital to home by utilizing continuous glucose monitoring systems. It aims to increase patient awareness and satisfaction regarding blood glucose monitoring through the use of devices like the Libre 3 Plus and Dexcom G7. Eligible participants include adults with hyperglycemia requiring insulin therapy, who will be monitored for their glucose levels post-discharge. The study seeks to evaluate the effectiveness of these monitoring systems in improving patient outcomes.
Why it matters
Potential benefit: If successful, this approach could lead to better diabetes management and improved patient satisfaction for individuals transitioning from hospital care to home.
How similar studies have gone: Other studies have shown positive outcomes with continuous glucose monitoring in diabetes management, indicating that this approach is supported by existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Non-pregnant adults, ages greater than or equal to 18 years, admitted to VUMC * Able to give informed consent * Hyperglycemia requiring insulin therapy including subcutaneous insulin injection or continuous subcutaneous insulin infusion (patient's own insulin pump) during hospitalization and at the time of discharge * POC glucose or venous glucose levels in the 24 hours prior to participation need to be 70-350 mg/dL * Need glucose readings greater than or equal to one time per day * Mental status and dexterity adequate to use Libre 3 Plus or Dexcom G7 sensors with Libre 3 or Dexcom G7 application on patient's smartphone Exclusion Criteria: * Currently using Libre 3 Plus or Dexcom G7 CGMS during hospitalization or have used Libre 3 Plus or Dexcom G7 CGMS in the past 3 months * Does not have smartphone compatible with Libre 3 App or Dexcom G7 App * Received chemotherapy during current hospitalization * Planning on major surgery within 10-15 days * Hemodialysis or peritoneal dialysis * Requiring vasopressors, intubation, sedation, or admission to an intensive care unit * Vitamin C use of more than 500 milligrams per day * Hydroxyurea use * Acetaminophen use of more than 4 grams per day or 1 gram every 6 hours * Significant pitting edema (3+ or greater) i.e. cirrhosis with ascites, congestive heart failure with edema, nephrotic syndrome, or signs of poor perfusion * Presentation in diabetic ketoacidosis or hyperosmotic nonketotic state * Skin allergy to adhesives
Where it's running
-
Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Study coordinator: Angel Morvant, MD
- Email: angel.morvant@vumc.org
- Phone: 615-343-8332
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Short versus long intermittent hypoxic-hyperoxic training for people with type 2 diabetes, including older adults
This study will see if short (3-day) or longer (10-day) sessions of intermittent low-oxygen/high-oxygen breathing improve blood sugar control in people aged 50–74 with type 2 diabetes.
-
Thai PainPREDICT for detecting neuropathic pain in people with diabetes
This project will test a Thai-language PainPREDICT questionnaire and a companion mobile app to help identify neuropathic pain in adults with type 1 or type 2 diabetes.
-
Cardiovascular health in children and young adults with chronic conditions
This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
Lifestyle change program to help type 2 diabetes go into remission in Pakistan
This study tests whether a structured, plant-predominant lifestyle program can put adults with type 2 diabetes in Lahore, Pakistan into remission for the first six months.
-
Maltodextrin vs Sugar Water for Pre-Surgery Carbohydrate Loading in Older Adults
This study tests whether a maltodextrin drink before surgery leaves less fluid in the stomach than sugar water for adults 60 and older undergoing leg surgery with spinal or epidural anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.